Apr 23 |
Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
|
Apr 5 |
After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX)
|
Apr 4 |
All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy
|
Apr 1 |
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Feb 2 |
Genelux files for a $300M mixed securities shelf
|
Dec 15 |
Insider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX)
|
Nov 27 |
HC Wainwright starts Genelux at buy, cites Olvi-Vec potential
|
Nov 27 |
Genelux gets fast track status for Olvi-Vec in ovarian cancer
|
Nov 27 |
Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer
|
Nov 17 |
Genelux Corporation (NASDAQ:GNLX) most popular amongst retail investors who own 57%, insiders hold 25%
|